MX9102475A - HETERO CYCLIC COMPOUNDS. - Google Patents

HETERO CYCLIC COMPOUNDS.

Info

Publication number
MX9102475A
MX9102475A MX9102475A MX9102475A MX9102475A MX 9102475 A MX9102475 A MX 9102475A MX 9102475 A MX9102475 A MX 9102475A MX 9102475 A MX9102475 A MX 9102475A MX 9102475 A MX9102475 A MX 9102475A
Authority
MX
Mexico
Prior art keywords
cyclic compounds
hetero cyclic
hetero
compounds
cyclic
Prior art date
Application number
MX9102475A
Other languages
Spanish (es)
Inventor
Martin Paul Edwards
John David Sherwood
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of MX9102475A publication Critical patent/MX9102475A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9102475A 1990-12-12 1991-12-10 HETERO CYCLIC COMPOUNDS. MX9102475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027018A GB9027018D0 (en) 1990-12-12 1990-12-12 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
MX9102475A true MX9102475A (en) 1992-06-01

Family

ID=10686919

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102475A MX9102475A (en) 1990-12-12 1991-12-10 HETERO CYCLIC COMPOUNDS.

Country Status (28)

Country Link
US (1) US5294636A (en)
EP (1) EP0490649B1 (en)
JP (1) JP2650807B2 (en)
KR (1) KR100194479B1 (en)
CN (2) CN1032469C (en)
AP (1) AP286A (en)
AT (1) ATE145199T1 (en)
AU (1) AU656344B2 (en)
CA (1) CA2056067C (en)
CZ (1) CZ288151B6 (en)
DE (1) DE69123123T2 (en)
DK (1) DK0490649T3 (en)
ES (1) ES2094797T3 (en)
FI (1) FI101296B1 (en)
GB (2) GB9027018D0 (en)
GR (1) GR3021605T3 (en)
HK (1) HK81497A (en)
HU (2) HU213109B (en)
IE (1) IE914316A1 (en)
IL (1) IL100090A (en)
MX (1) MX9102475A (en)
MY (1) MY108629A (en)
NZ (1) NZ240940A (en)
PH (1) PH30041A (en)
RU (1) RU2107682C1 (en)
SK (1) SK279018B6 (en)
TW (1) TW222264B (en)
ZA (1) ZA919772B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0455596B1 (en) * 1990-05-04 1994-11-02 Novartis AG Substituted Indoles
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (en) * 1992-10-08 1993-10-29 Ici Plc Pharmaceutical agents.
DE4235133A1 (en) * 1992-10-19 1994-04-21 Bayer Ag Crystalline (R) - (-) - 2-cycloheptyl-N-methylsulfonyl- [4- (2-quinolinyl-methoxy) phenyl] acetamide
IS1736B (en) 1993-10-01 1999-12-30 Astra Ab Methods and devices that promote increased particle aggregation
CN1110300C (en) * 1993-10-01 2003-06-04 阿斯特拉公司 Process I
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
JP2008531721A (en) * 2005-03-03 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド Nanoparticulate compositions of heterocyclic amide derivatives
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
EP2170825A2 (en) * 2007-07-30 2010-04-07 Auspex Pharmaceuticals, Inc. Substituted indoles
TWI469965B (en) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co Ethynylindole compounds
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
CN103396353B (en) * 2013-08-23 2015-05-20 海南通用三洋药业有限公司 Amorphous zafirlukast and preparation method thereof
WO2015110394A1 (en) 2014-01-22 2015-07-30 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
PT109030B (en) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. PREPARATION OF ZAFIRLUCAST INHALABLE PARTICULES
WO2018140858A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
AU2022276190A1 (en) 2021-05-19 2024-01-18 Quercis Pharma AG Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives

Also Published As

Publication number Publication date
HU913863D0 (en) 1992-02-28
JP2650807B2 (en) 1997-09-10
HU211125A9 (en) 1995-10-30
AP286A (en) 1993-09-26
CZ288151B6 (en) 2001-05-16
GB9027018D0 (en) 1991-01-30
CS375891A3 (en) 1992-06-17
DE69123123T2 (en) 1997-03-06
CA2056067A1 (en) 1992-06-13
HUT60717A (en) 1992-10-28
ZA919772B (en) 1992-09-30
DK0490649T3 (en) 1997-04-21
ES2094797T3 (en) 1997-02-01
FI101296B (en) 1998-05-29
GB9126353D0 (en) 1992-02-12
US5294636A (en) 1994-03-15
CA2056067C (en) 2001-09-04
AU656344B2 (en) 1995-02-02
TW222264B (en) 1994-04-11
HK81497A (en) 1997-06-27
GB2250743A (en) 1992-06-17
GR3021605T3 (en) 1997-02-28
RU2107682C1 (en) 1998-03-27
IL100090A (en) 1996-09-12
CN1063100A (en) 1992-07-29
KR100194479B1 (en) 1999-06-15
EP0490649B1 (en) 1996-11-13
EP0490649A1 (en) 1992-06-17
DE69123123D1 (en) 1996-12-19
AU8899591A (en) 1992-06-18
IL100090A0 (en) 1992-08-18
SK279018B6 (en) 1998-05-06
FI915825A0 (en) 1991-12-11
PH30041A (en) 1996-11-08
FI101296B1 (en) 1998-05-29
KR920012031A (en) 1992-07-25
AP9100341A0 (en) 1992-01-31
NZ240940A (en) 1994-05-26
CN1032469C (en) 1996-08-07
CN1074411C (en) 2001-11-07
IE914316A1 (en) 1992-06-17
FI915825A (en) 1992-06-13
MY108629A (en) 1996-10-31
GB2250743B (en) 1995-02-15
ATE145199T1 (en) 1996-11-15
CN1148491A (en) 1997-04-30
JPH04266872A (en) 1992-09-22
HU213109B (en) 1997-02-28

Similar Documents

Publication Publication Date Title
MX9102475A (en) HETERO CYCLIC COMPOUNDS.
DE69005858T3 (en) Heterocyclic compounds.
NO900174D0 (en) CYCLIC AMINE COMPOUNDS.
FI922964A0 (en) CYCLIC IMIDDERIVAT.
DE69110161D1 (en) Rubber compound.
MX9206455A (en) HETERO CYCLIC COMPOUNDS.
DE68915928T2 (en) Benzoheterocyclic compounds.
FI903190A0 (en) HOERNSTYCKE FOER ETT LEDNINGSKANALSYSTEM.
ATE126217T1 (en) PHENOXYHETEROCYCLIC COMPOUNDS.
DE69121734D1 (en) Spiroisoindole compounds
MX9205793A (en) HETERO CYCLIC COMPOUNDS
DE69019801D1 (en) Heterocyclic compounds.
FI924076A0 (en) CYCLIC NITRONER.
DE59103481D1 (en) o-aminoazo compounds.
MX9201398A (en) HETERO CYCLIC COMPOUNDS.
MX9201407A (en) HETERO CYCLIC COMPOUNDS.
MX9201424A (en) HETERO CYCLIC COMPOUNDS.
MX9201399A (en) HETERO CYCLIC COMPOUNDS.
NO932258D0 (en) HETEROCYCLIC, PESTICATIVE COMPOUNDS
DE59104042D1 (en) Chlorophenylalkoxyalkyl compounds.
MX9202573A (en) HETERO CYCLIC DERIVATIVES.
MX9205468A (en) HETERO CYCLIC COMPOUNDS
DE59005786D1 (en) Heterocyclic compounds.
DE69113874D1 (en) Cyclic ether derivatives.
FI86279B (en) OEPPNINGS- OCH STAENGNINGSMEKANISM FOER ETT FORDONS DRAGKOPPLING.

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HC Change of company name or juridical status

Owner name: JOHNSON & JOHNSON

PD Change of proprietorship

Owner name: ASTRAZENECA UK LIMITED

MM Annulment or lapse due to non-payment of fees